Navigation Links
Medarex Announces Preclinical Data from Multiple Research Programs Demonstrating Anti-Tumor Activity in Cancer
Date:4/21/2009

- Data Presented at the American Association for Cancer Research -

PRINCETON, N.J., April 21 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) today announced preclinical efficacy and safety data from multiple programs, including antibodies to novel and potentially important cancer targets (CXCR4, fucosyl-GM1, glypican-3, mesothelin, CD70) and additional research in the area of antibody-drug conjugates. Data from the studies were presented at the Annual Meeting of the American Association for Cancer Research (AACR), April 18-22, 2009, in Colorado.

Characterization of MDX-1338, a human anti-CXCR4 antibody proposed for therapeutic application in AML and ALL (Abstract #LB-150)

CXCR4 is a seven-transmembrane, G-protein-coupled receptor in the CXC chemokine receptor family that is expressed on a variety of cancers including leukemias, lymphomas, breast, lung, colon, pancreatic, and ovarian cancer. In preclinical studies, MDX-1338, a fully human anti-CXCR4 antibody, effectively blocked the binding of CXCR4 to its ligand, CXCL12, thereby inhibiting chemotaxis and migration responses. In addition, MDX-1338 also reduced tumor growth in acute myelogenous leukemia and lymphoma xenograft models.

Efficacy of MDX-1110, an anti-Fucosyl-GM1 antibody in a SCLC tumor model (Abstract #838)

Fucosyl-GM1 is a ganglioside, a component of the cell plasma membrane, that is expressed on most small cell lung cancers (SCLC). In in vitro preclinical studies, a fully human, non-fucosylated anti-fucosyl-GM1 antibody, MDX-1110, demonstrated robust cytotoxic effector function (both antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity) for killing tumor cells. Additionally, MDX-1110 showed a favorable safety and toxicity profile. MDX-1110 also demonstrated potent anti-tumor a
'/>"/>

SOURCE Medarex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Medarex Announces Enhanced Activity Data with Second Generation Anti-CD30 Antibody for Malignant Lymphoma
2. Medarex Announces Initiation of Phase 1b Clinical Development Program with MDX-1106 for the Treatment of Cancer
3. Medarex Receives Milestone Payment for Investigational Antibody Targeting Integrin Receptors
4. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
5. Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology
6. Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus
7. Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-PD-L1 Antibody, MDX-1105
8. Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City
9. Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis
10. Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
11. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , Aug. 4, 2015 Young ... supplies and equipment, today announced the acquisition of ... Products Laboratories, Inc. ("MPL PDCMD"). MPL PDCMD manufactures ... in preventive and restorative dental procedures. ... of our business in attractive, high-growth segments," said ...
(Date:8/4/2015)... 2015  Eli Lilly and Company (NYSE: LLY ... (UCSD) of its intent to end its contract with ... in Asymptomatic Alzheimer,s disease (A4) study. The A4 study ... preclinical stage of Alzheimer,s disease in older individuals who ... PET scan, but do not show symptoms of memory ...
(Date:8/4/2015)...  IRIDEX Corporation (Nasdaq: IRIX ) today announced ... as chief financial officer since 2008 and as chief ... the Company, effective August 21, 2015, to accept the ... intends to continue to serve in the CFO/COO role ... filing. CEO William M. Moore ...
Breaking Medicine Technology:Young Innovations Announces Acquisition of Medical Products Laboratories' Professional Dental Contract Manufacturing Division 2Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 2Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 3IRIDEX Chief Financial Officer Resigns to Accept Another Opportunity 2
... CITY, Feb. 21, 2012 Genomma Lab Internacional, S.A.B. de ... a non-binding proposal to acquire all of the outstanding shares ... ) common stock for $16.60 dollars per share in cash. ... including Prestige,s net debt. Genomma,s all-cash proposal ...
... Corporation (NYSE: SHP ) ("ShangPharma" or the ... development outsourcing company, today announced that it will attend ... in Boston, Massachusetts from March 5-7, 2012. ... Relations of ShangPharma, will present at the conference and ...
Cached Medicine Technology:Genomma Lab Internacional Announces Non-binding Proposal to Acquire Prestige Brands Holdings for $16.60 Per Share in Cash 2Genomma Lab Internacional Announces Non-binding Proposal to Acquire Prestige Brands Holdings for $16.60 Per Share in Cash 3Genomma Lab Internacional Announces Non-binding Proposal to Acquire Prestige Brands Holdings for $16.60 Per Share in Cash 4Genomma Lab Internacional Announces Non-binding Proposal to Acquire Prestige Brands Holdings for $16.60 Per Share in Cash 5
(Date:8/4/2015)... ... 2015 , ... How cool is it to check in at your favorite ... "Now" feature will soon allow you to do just that. , Ahhaa is releasing ... the now feature. , Users will soon get to share what inspires them about ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... Statement by ... applauds the introduction of the Mental Health Reform Act of 2015 by ... comprehensive mental health reform a reality in America. , “This legislation and ...
(Date:8/4/2015)... ... August 05, 2015 , ... The Journal of Pain Research has ... corresponding author Professor Akiko Okifuji says “Both obesity and chronic pain are serious public ... say that one causes the other. Rather, there appear to be multiple factors that ...
(Date:8/4/2015)... ... ... Sponsored by Gila River Casinos, the charity event helps raise funds and ... to the New Foundation AZ spokesperson , the organization is still looking for ... foursome for the tournament, as well as getting their company advertised on a banner ...
(Date:8/4/2015)... ... August 04, 2015 , ... World Patent Marketing, a ... Rack, a fitness invention that eliminates the need to have a partner or ... Clubs industry is worth $30 billion," says Scott Cooper, CEO and Creative Director ...
Breaking Medicine News(10 mins):Health News:Ahhaa App Soon to Release the "Now" Feature 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3Health News:The Association between Chronic Pain and Obesity published by Dove Medical Press 2Health News:The New Foundation AZ to Host Charity Golf Tournament 2Health News:The New Foundation AZ to Host Charity Golf Tournament 3Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 2Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 3Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 4Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 5Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 6
... France celebrated the summer solstice in the wee small hours ... that drew 10 million revellers onto the streets , while ... ,In Paris, the mood and vibe changed from area to ... and danced in the narrow streets as small-time artists enjoyed ...
... Medical Association will decide later this month whether internet and ... will vote on the issue at the AMA national meeting ... disease is teens holing up in their rooms, ignoring friends, ... belligerence soars. ,Video games for certain kids can be ...
... in the world, 60 patients who have recently suffered a ... from their own bone marrow during routine coronary bypass ... stem cells will repair heart muscle cells damaged by the ... heart contraction. ,Professor Jeremy Pearson, Associate Medical Director ...
... reportedly devastated after suffering a miscarriage of the baby she was ... caught in a controversy after the Big Brother racial row with ... came as a surprise. ,Sadly for Goody and Tweed, ... TV star miscarried. ,And though she was taken to ...
... blow to British Prime Minister Tony Blair, his wife Cherie ... the legislation that imposes ban on smoking from July 1 ... advice as to how the smoking ban may breach the ... club in St James's, Central London, which has bondage tables ...
... heavy, overweight children share something else in common as well. ... has revealed that each one of them has high levels ... ,The children presented high levels of apoB48 even as ... adults, remained in the normal range. ,In ...
Cached Medicine News:Health News:France Celebrates Summer With All-night Music Fest; NY Swings Along 2Health News:Video Game Addiction to Be Termed as a Medical Condition 2Health News:A New Milestone in Stem Cell Research 2Health News:Cherie Blair to Challenge Hubbys Smoking Ban on Human Rights Ground 2Health News:Researchers Identify New Risk Marker for Obese Children 2
The incorporation of a reverse osmosis (RO) system and an ultrapure water system into a single stand-alone tower provides numerous benefits to the busy laboratory....
... up to 12 L/min of Type I ... Demand, The Super-Q Plus System is designed ... which has been pretreated by reverse osmosis, ... produce ultrapure water quality which exceeds Type ...
... for speed, stability and durability. Back-lighted ... modes, multiple units of measure, piece ... print, and GLP/GMP/ISO output including date ... Built-in, motor-driven internal calibration mass ...
... weighing mechanism for speed, stability and ... analog display modes, multiple units of ... functions, auto print, and GLP/GMP/ISO output ... built-in clock. Touch-key calibration with external ...
Medicine Products: